Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study
NCT ID: NCT02176174
Last Updated: 2017-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1068318 participants
OBSERVATIONAL
2013-12-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that different ethnic groups have differing associations with the range of cardiovascular diseases studied.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
NCT00377702
White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER Study
NCT02014610
Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study
NCT01937065
Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
NCT02244853
An Observational Study of Natural History of Cardiovascular Diseases
NCT02077023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to examine the differing associations between four ethnic groups and the initial lifetime presentation of a broad range of cardiovascular diseases, including chronic presentations such as stable angina. The hypothesis is that there will be heterogeneity of associations between the different ethnic groups and the full range of cardiovascular diseases studied.
The study will use data from the CALIBER data set of clinically collected electronic health record data from England.
This study is part of the CALIBER (Cardiovascular disease research using linked bespoke studies and electronic records) programme funded over 5 years from the National Institute for Health Research (NIHR) and Wellcome Trust. The central theme of the CALIBER research is linkage of the Myocardial Ischaemia National Audit Project (MINAP) with primary care (Clinical Practice Research Datalink - CPRD) and other resources. The overarching aim of CALIBER is to better understand the aetiology and prognosis of specific coronary phenotypes across a range of causal domains, particularly where electronic records provide a contribution beyond traditional studies. CALIBER has received both Ethics approval (ref 09/H0810/16) and ECC approval (ref ECC 2-06(b)/2009 CALIBER data set).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
White
Self-reported ethnic group of Black, using the United Kingdom Census categories, as recorded in electronic health records.
No interventions assigned to this group
Black
Self-reported ethnic group of Black, using the United Kingdom Census categories, as recorded in electronic health records.
No interventions assigned to this group
South Asian
Self-reported ethnic group of South Asian, using the United Kingdom Census categories, as recorded in electronic health records.
No interventions assigned to this group
Mixed/Other
Self-reported ethnic group of Mixed or other, using the United Kingdom Census categories, as recorded in electronic health records.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered with a participating general practice during the study period
* Minimum one year of records prior to study entry meeting CPRD data quality
Exclusion Criteria
* Patients without record of gender
* Patients with prior atherosclerotic disease, as recorded in primary care or hospitalisation data
* Pregnant women in the 6 months before the eligibility date
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wellcome Trust
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
London School of Hygiene and Tropical Medicine
OTHER
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie George
Honorary Research Associate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie George, Phd
Role: PRINCIPAL_INVESTIGATOR
University College, London
Harry Hemingway, PhD
Role: STUDY_DIRECTOR
University College, London
References
Explore related publications, articles, or registry entries linked to this study.
Denaxas SC, George J, Herrett E, Shah AD, Kalra D, Hingorani AD, Kivimaki M, Timmis AD, Smeeth L, Hemingway H. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol. 2012 Dec;41(6):1625-38. doi: 10.1093/ije/dys188. Epub 2012 Dec 5.
George J, Mathur R, Shah AD, Pujades-Rodriguez M, Denaxas S, Smeeth L, Timmis A, Hemingway H. Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients. PLoS One. 2017 Jun 9;12(6):e0178945. doi: 10.1371/journal.pone.0178945. eCollection 2017.
Related Links
Access external resources that provide additional context or updates about the study.
CALIBER web site and data portal
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
086091/Z/08/Z
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RP-PG-0407-10314
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CALIBER 13-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.